177 related articles for article (PubMed ID: 22821631)
1. The plexiform neurofibroma microenvironment.
Yang FC; Staser K; Clapp DW
Cancer Microenviron; 2012 Dec; 5(3):307-10. PubMed ID: 22821631
[TBL] [Abstract][Full Text] [Related]
2. Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells.
Staser K; Yang FC; Clapp DW
Curr Opin Hematol; 2010 Jul; 17(4):287-93. PubMed ID: 20571392
[TBL] [Abstract][Full Text] [Related]
3. Mast cells and the neurofibroma microenvironment.
Staser K; Yang FC; Clapp DW
Blood; 2010 Jul; 116(2):157-64. PubMed ID: 20233971
[TBL] [Abstract][Full Text] [Related]
4. Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.
Yang FC; Ingram DA; Chen S; Zhu Y; Yuan J; Li X; Yang X; Knowles S; Horn W; Li Y; Zhang S; Yang Y; Vakili ST; Yu M; Burns D; Robertson K; Hutchins G; Parada LF; Clapp DW
Cell; 2008 Oct; 135(3):437-48. PubMed ID: 18984156
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.
Staser K; Yang FC; Clapp DW
Annu Rev Pathol; 2012; 7():469-95. PubMed ID: 22077553
[TBL] [Abstract][Full Text] [Related]
6. The
White EE; Rhodes SD
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473354
[TBL] [Abstract][Full Text] [Related]
7. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.
Yang FC; Chen S; Clegg T; Li X; Morgan T; Estwick SA; Yuan J; Khalaf W; Burgin S; Travers J; Parada LF; Ingram DA; Clapp DW
Hum Mol Genet; 2006 Aug; 15(16):2421-37. PubMed ID: 16835260
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.
Yang FC; Ingram DA; Chen S; Hingtgen CM; Ratner N; Monk KR; Clegg T; White H; Mead L; Wenning MJ; Williams DA; Kapur R; Atkinson SJ; Clapp DW
J Clin Invest; 2003 Dec; 112(12):1851-61. PubMed ID: 14679180
[TBL] [Abstract][Full Text] [Related]
9. Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.
Le LQ; Liu C; Shipman T; Chen Z; Suter U; Parada LF
Cancer Res; 2011 Jul; 71(13):4686-95. PubMed ID: 21551250
[TBL] [Abstract][Full Text] [Related]
10. The role of nerve microenvironment for neurofibroma development.
Liao CP; Pradhan S; Chen Z; Patel AJ; Booker RC; Le LQ
Oncotarget; 2016 Sep; 7(38):61500-61508. PubMed ID: 27517146
[TBL] [Abstract][Full Text] [Related]
11. New insights into the neurofibroma tumor cells of origin.
Li S; Chen Z; Le LQ
Neurooncol Adv; 2020 Jul; 2(Suppl 1):i13-i22. PubMed ID: 32642729
[TBL] [Abstract][Full Text] [Related]
12. Plexiform-like neurofibromas develop in the mouse by intraneural xenograft of an NF1 tumor-derived Schwann cell line.
Perrin GQ; Fishbein L; Thomson SA; Thomas SL; Stephens K; Garbern JY; DeVries GH; Yachnis AT; Wallace MR; Muir D
J Neurosci Res; 2007 May; 85(6):1347-57. PubMed ID: 17335073
[TBL] [Abstract][Full Text] [Related]
13. Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of
Burks CA; Rhodes SD; Bessler WK; Chen S; Smith A; Gehlhausen JR; Hawley ET; Jiang L; Li X; Yuan J; Lu Q; Jacobsen M; Sandusky GE; Jones DR; Clapp DW; Blakeley JO
Mol Cancer Ther; 2019 Dec; 18(12):2321-2330. PubMed ID: 31527226
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
15. Analysis of somatic NF1 promoter methylation in plexiform neurofibromas and Schwann cells.
Fishbein L; Eady B; Sanek N; Muir D; Wallace MR
Cancer Genet Cytogenet; 2005 Mar; 157(2):181-6. PubMed ID: 15721644
[TBL] [Abstract][Full Text] [Related]
16. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.
Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E
Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas.
Ferguson MJ; Rhodes SD; Jiang L; Li X; Yuan J; Yang X; Zhang S; Vakili ST; Territo P; Hutchins G; Yang FC; Ingram DA; Clapp DW; Chen S
Pediatr Blood Cancer; 2016 Feb; 63(2):206-13. PubMed ID: 26375012
[TBL] [Abstract][Full Text] [Related]
18. Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis.
Liao CP; Booker RC; Brosseau JP; Chen Z; Mo J; Tchegnon E; Wang Y; Clapp DW; Le LQ
J Clin Invest; 2018 Jul; 128(7):2848-2861. PubMed ID: 29596064
[TBL] [Abstract][Full Text] [Related]
19. Plexiform neurofibromas in NF1: toward biologic-based therapy.
Packer RJ; Gutmann DH; Rubenstein A; Viskochil D; Zimmerman RA; Vezina G; Small J; Korf B
Neurology; 2002 May; 58(10):1461-70. PubMed ID: 12041525
[TBL] [Abstract][Full Text] [Related]
20. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
